Skip to main content

Peer Review reports

From: Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses

Original Submission
4 Mar 2020 Submitted Original manuscript
1 Apr 2020 Author responded Author comments - Toshihiko Matsumoto
Resubmission - Version 2
1 Apr 2020 Submitted Manuscript version 2
6 Apr 2020 Reviewed Reviewer Report - Bianca Mostert
29 Apr 2020 Reviewed Reviewer Report
17 May 2020 Author responded Author comments - Toshihiko Matsumoto
Resubmission - Version 3
17 May 2020 Submitted Manuscript version 3
22 May 2020 Author responded Author comments - Toshihiko Matsumoto
Resubmission - Version 4
22 May 2020 Submitted Manuscript version 4
27 May 2020 Author responded Author comments - Toshihiko Matsumoto
Resubmission - Version 5
27 May 2020 Submitted Manuscript version 5
4 Jun 2020 Author responded Author comments - Toshihiko Matsumoto
Resubmission - Version 6
4 Jun 2020 Submitted Manuscript version 6
Publishing
13 Jul 2020 Editorially accepted
22 Jul 2020 Article published 10.1186/s12885-020-07176-7

You can find further information about peer review here.

Back to article page